Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia, Ibex support pathologists in detecting prostate cancer

Proscia
By Author Proscia | March 13, 2021
Proscia and Ibex Medical Analytics are teaming up to support pathologists in detecting prostate cancer through the use of artificial intelligence (AI) software.

The AI software will bring together Ibex’s Galen Prostate software with Proscia’s Concentriq image and data management system to triage patients, detect prostate cancer, and grade prostate core needle biopsies.

Galen Prostate will be available to select users of Concentriq in the U.S. and Europe, the firms said.


Our website uses cookies. By using this site, you agree to its use of cookies.